Track Demant A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Demant A/S DEMANT.CO Open Demant A/S in new tab

229.60 DKK
P/E
20.45
EPS
11.20
P/B
4.91
ROE
24.20
Beta
0.72
Target Price
237.79 DKK
Loading chart...
Key Metrics
Earnings dateMay 27, 2026
P/E20.45
EPS11.20
Book Value46.67
Price to Book4.91
Debt/Equity211.59
% Insiders58.900%
Growth
Revenue Growth0.03%
Earnings Growth-0.63%
Estimates
Forward P/E15.34
Forward EPS14.93
Target Mean Price237.79

DCF Valuation

Tweak assumptions to recompute fair value for Demant A/S (DEMANT.CO)
Currency: DKK
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Demant A/S Logo Demant A/S Analysis (DEMANT.CO)

Denmark Health Care Official Website Stock

Is Demant A/S a good investment? Demant A/S (DEMANT.CO) is currently trading at 229.60 DKK. Market analysts have a consensus price target of 237.79 DKK. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 20.45. This valuation is generally in line with the broader market.

Earnings Schedule: Demant A/S is expected to release its next earnings report on May 27, 2026. The market consensus estimate for Forward EPS is 14.93.

Investor FAQ

Does Demant A/S pay a dividend?

No, it does not currently pay a dividend.

What asset class is Demant A/S?

Demant A/S is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 27, 2026. The company currently has a trailing EPS of 11.20.

Company Profile

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Exchange Ticker
CPH (Denmark) DEMANT.CO
PNK (United States) WILLF

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
May 25, 2016 5.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion